1. Home
  2. TNK vs SLNO Comparison

TNK vs SLNO Comparison

Compare TNK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$76.70

Market Cap

2.9B

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$53.00

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNK
SLNO
Founded
2007
1999
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.3B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
TNK
SLNO
Price
$76.70
$53.00
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$80.00
$83.00
AVG Volume (30 Days)
343.3K
1.6M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
2.55%
N/A
EPS Growth
N/A
108.90
EPS
N/A
0.59
Revenue
N/A
$1,450,788.00
Revenue This Year
N/A
$150.46
Revenue Next Year
N/A
$50.37
P/E Ratio
$8.05
$89.83
Revenue Growth
N/A
138.82
52 Week Low
$41.05
$29.43
52 Week High
$83.99
$89.12

Technical Indicators

Market Signals
Indicator
TNK
SLNO
Relative Strength Index (RSI) 47.98 77.32
Support Level $71.94 $48.91
Resistance Level $80.97 $55.47
Average True Range (ATR) 2.93 0.05
MACD -0.60 -0.52
Stochastic Oscillator 16.73 100.00

Price Performance

Historical Comparison
TNK
SLNO

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: